Ranbaxy settles with Takeda on Actos suit
15 March 2010
Anju Ghangurde
Ranbaxy Laboratories has settled outstanding patent litigation with
Takeda Pharmaceutical Company, allowing it to launch a generic version of Takeda's antidiabetic, Actos (pioglitazone hydrochloride), in the US.
Under the deal, Ranbaxy can launch its generic equivalent of Actos on August 17th...
Please Login to read the full article.
15 March 2010
Anju Ghangurde
Under the deal, Ranbaxy can launch its generic equivalent of Actos on August 17th...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Mylan suit pushes FDA to decide immediately on Ranbaxy ANDA for generic Lipitor
- Glenmark settles with Genzyme and Daiichi Sankyo over US Welchol generics
- Pfizer settles US Lipitor patent suit against Dr Reddy's
- Sun set for generic Uroxatral ER launch in US with 180-day exclusivity
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
